BIOMAT Database Logo BIOMAT Database Logo

Kupffer cells may autoregulate interleukin 1 production by producing interleukin 1 inhibitor and prostaglandin E2. 1988

M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Rat Kupffer cells stimulated with bacterial lipopolysaccharide (LPS) produced high levels of interleukin 1 (IL-1), as determined by thymocyte proliferation assay. Indomethacin revealed a dose-dependent augmentation in IL-1 production, in parallel with a dose-dependent reduction in prostaglandin E2 production by Kupffer cells. The addition of exogenous prostaglandin E2, dibutyryl cAMP, or isoproterenol led to a dose-dependent suppression of IL-1 production. The supernatant from LPS-stimulated Kupffer cells also contained factors that inhibited IL-1-induced thymocyte proliferation. Upon gel filtration, two inhibitory peaks, at apparent MW of 27,000 and 6000, were obtained. The latter but not the former fraction also affected interleukin 2 (IL-2)-induced thymocyte proliferation. Increasing amounts of IL-1 overcame the inhibitory activity derived from the 27,000 MW fractions. These results suggest to us that prostaglandin E2 and IL-1 inhibitor released by Kupffer cells may be involved in negative self-control in regulating IL-1 production and its action.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007375 Interleukin-1 A soluble factor produced by MONOCYTES; MACROPHAGES, and other cells which activates T-lymphocytes and potentiates their response to mitogens or antigens. Interleukin-1 is a general term refers to either of the two distinct proteins, INTERLEUKIN-1ALPHA and INTERLEUKIN-1BETA. The biological effects of IL-1 include the ability to replace macrophage requirements for T-cell activation. IL-1,Lymphocyte-Activating Factor,Epidermal Cell Derived Thymocyte-Activating Factor,Interleukin I,Macrophage Cell Factor,T Helper Factor,Epidermal Cell Derived Thymocyte Activating Factor,Interleukin 1,Lymphocyte Activating Factor
D007545 Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant. Isoprenaline,Isopropylarterenol,4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol,Euspiran,Isadrin,Isadrine,Isopropyl Noradrenaline,Isopropylnoradrenaline,Isopropylnorepinephrine,Isoproterenol Hydrochloride,Isoproterenol Sulfate,Isuprel,Izadrin,Norisodrine,Novodrin,Hydrochloride, Isoproterenol,Noradrenaline, Isopropyl,Sulfate, Isoproterenol
D007728 Kupffer Cells Specialized phagocytic cells of the MONONUCLEAR PHAGOCYTE SYSTEM found on the luminal surface of the hepatic sinusoids. They filter bacteria and small foreign proteins out of the blood and dispose of worn out red blood cells. Kupffer Cell,Cell, Kupffer,Cells, Kupffer
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008222 Lymphokines Soluble protein factors generated by activated lymphocytes that affect other cells, primarily those involved in cellular immunity. Lymphocyte Mediators,Mediators, Lymphocyte
D008297 Male Males
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular

Related Publications

M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Interleukin-6 production by endotoxin-stimulated Kupffer cells is regulated by prostaglandin E2.
June 1990, The Journal of surgical research,
M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Interferon gamma stimulates prostaglandin E2 production by mouse Kupffer cells.
August 1990, Prostaglandins, leukotrienes, and essential fatty acids,
M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Interleukin-2 augmentation of interleukin-1 and prostaglandin E2 production.
May 1989, Journal of leukocyte biology,
M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.
February 1986, The Journal of clinical investigation,
M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s).
October 1986, The Journal of clinical investigation,
M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Prostaglandin production by isolated Kupffer cells.
October 1990, Gastroenterologia Japonica,
M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Nitric oxide mediates interleukin-1-induced prostaglandin E2 production by vascular smooth muscle cells.
July 1993, Biochemical and biophysical research communications,
M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Recombinant interleukin-1 stimulates prostaglandin E2 production by osteoblastic cells: synergy with parathyroid hormone.
June 1988, Calcified tissue international,
M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Human monocyte heterogeneity: interleukin 1 and prostaglandin E2 production by separate subsets.
January 1985, European journal of immunology,
M Shirahama, and H Ishibashi, and Y Tsuchiya, and S Kurokawa, and K Hayashida, and Y Okumura, and Y Niho
Prostaglandin E2 potentiates interleukin-1 beta induced interleukin-6 production by human gingival fibroblasts.
July 1996, Journal of clinical periodontology,
Copied contents to your clipboard!